Search Results - Mark A. Tomai
- Showing 1 - 2 results of 2
-
1
Immunogenicity and safety of an Entamoeba histolytica adjuvanted protein vaccine candidate (LecA+GLA-3M-052 liposomes) in rhesus macaques by Mayuresh M. Abhyankar, Feifan Xu, Deborah Chavez, Anna Goodroe, Elda Mendoza, Christopher Chen, Dhiraj K. Singh, Fernando Varnador, Sandra J. Sivananthan, Robert Kinsey, William R. Lykins, Brynn M. Murphy, Andrew R. Martin, Mark A. Tomai, Soutik Ghosal, Corey Casper, Karl Pedersen, William A. Petri, Christopher B. Fox
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Choice of adjuvant and antigen composition alters the immunogenic profile of a SARS-CoV-2 subunit vaccine by William R. Lykins, Jeroen Pollet, Jeroen Pollet, Jessica A. White, Brian Keegan, Brian Keegan, Leroy Versteeg, Leroy Versteeg, Ulrich Strych, Ulrich Strych, Wen-Hsiang Chen, Wen-Hsiang Chen, Raodoh Mohamath, Gabi Ramer-Denisoff, Sierra Reed, Samuel Beaver, Alana Gerhardt, Emily A. Voigt, Mark A. Tomai, Robert Sitrin, Robert K. M. Choy, Frederick J. Cassels, Peter J. Hotez, Peter J. Hotez, Peter J. Hotez, Peter J. Hotez, Maria Elena Bottazzi, Maria Elena Bottazzi, Maria Elena Bottazzi, Christopher B. Fox, Christopher B. Fox
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book